Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Janet Rader

Concepts (632)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
84
2022
276
13.160
Why?
Ovarian Neoplasms
37
2024
450
2.840
Why?
Papillomavirus Infections
18
2021
167
2.800
Why?
Endometrial Neoplasms
34
2019
137
2.460
Why?
Uterine Cervical Dysplasia
16
2017
49
2.450
Why?
Carcinoma, Squamous Cell
31
2018
330
2.050
Why?
Gene Expression Regulation, Neoplastic
18
2021
824
1.910
Why?
Human papillomavirus 16
8
2019
44
1.750
Why?
Female
190
2024
26560
1.610
Why?
Gene Expression Profiling
9
2021
1028
1.570
Why?
Papillomaviridae
16
2020
102
1.400
Why?
Antineoplastic Combined Chemotherapy Protocols
17
2013
994
1.320
Why?
DNA Methylation
21
2020
544
1.320
Why?
Genital Neoplasms, Female
10
2018
41
1.210
Why?
Human papillomavirus 18
5
2019
9
1.190
Why?
Humans
191
2024
49898
1.180
Why?
Genetic Predisposition to Disease
13
2024
507
1.140
Why?
Adult
92
2024
13346
1.120
Why?
Middle Aged
99
2024
12285
1.050
Why?
Neoplasm Staging
41
2019
749
1.050
Why?
Adenocarcinoma
18
2018
401
1.010
Why?
Polymorphism, Single Nucleotide
10
2019
482
0.980
Why?
MicroRNAs
7
2019
347
0.960
Why?
Fluorodeoxyglucose F18
15
2022
189
0.960
Why?
DNA-Binding Proteins
9
2021
424
0.950
Why?
Neoplasm Recurrence, Local
19
2024
626
0.940
Why?
Carcinoma
12
2010
139
0.910
Why?
Oncogene Proteins, Viral
4
2019
52
0.860
Why?
Radiopharmaceuticals
14
2022
204
0.810
Why?
Cervix Uteri
7
2017
42
0.810
Why?
Repressor Proteins
4
2019
149
0.810
Why?
Alphapapillomavirus
1
2021
13
0.770
Why?
DNA, Viral
6
2019
133
0.750
Why?
Cell Line, Tumor
18
2021
1388
0.740
Why?
Immunologic Factors
2
2014
112
0.730
Why?
Neoplasm Invasiveness
15
2020
268
0.700
Why?
Neoplasms
8
2022
1233
0.700
Why?
Genetic Markers
8
2017
103
0.680
Why?
Genes, Tumor Suppressor
8
2007
73
0.680
Why?
Aged
70
2024
9447
0.680
Why?
Neoplasm Proteins
10
2019
321
0.670
Why?
Immunoglobulins
3
2017
79
0.660
Why?
Genomics
4
2018
284
0.640
Why?
Biomedical Research
1
2022
241
0.630
Why?
Gene Silencing
5
2018
114
0.630
Why?
Vascular Endothelial Growth Factor A
2
2017
183
0.560
Why?
Cisplatin
7
2022
275
0.560
Why?
Proteomics
1
2019
292
0.550
Why?
Aged, 80 and over
36
2024
3136
0.540
Why?
Promoter Regions, Genetic
12
2020
467
0.530
Why?
HLA-C Antigens
2
2018
4
0.530
Why?
Receptors, KIR
2
2018
13
0.520
Why?
Positron-Emission Tomography
11
2013
286
0.510
Why?
Ubiquitin Thiolesterase
2
2021
17
0.500
Why?
Tumor Virus Infections
4
2006
46
0.500
Why?
Microsatellite Repeats
14
2007
37
0.500
Why?
Lymph Nodes
10
2010
257
0.500
Why?
Disease-Free Survival
17
2013
450
0.490
Why?
Hysterectomy
15
2022
88
0.490
Why?
Gynecologic Surgical Procedures
4
2010
28
0.490
Why?
Granulosa Cell Tumor
2
2024
2
0.470
Why?
Phenotype
4
2016
728
0.460
Why?
Prognosis
19
2021
1956
0.460
Why?
Lymphatic Metastasis
14
2019
226
0.450
Why?
Chromosomes, Human, Pair 6
4
2007
15
0.440
Why?
Alleles
5
2017
251
0.440
Why?
Nuclear Proteins
8
2009
242
0.440
Why?
Immunohistochemistry
13
2024
972
0.440
Why?
Loss of Heterozygosity
10
2007
77
0.440
Why?
Ovary
2
2008
114
0.420
Why?
Membrane Proteins
3
2005
347
0.410
Why?
Genotype
9
2018
538
0.410
Why?
Cell Movement
5
2021
245
0.400
Why?
Survival Analysis
14
2021
670
0.400
Why?
STAT3 Transcription Factor
3
2021
80
0.400
Why?
Peritoneal Neoplasms
4
2008
61
0.390
Why?
Ultrasonic Therapy
3
2001
34
0.390
Why?
Carcinoma, Endometrioid
6
2014
38
0.390
Why?
Genes, p53
2
2010
51
0.380
Why?
Cell Proliferation
6
2021
986
0.380
Why?
Risk Factors
13
2019
3604
0.370
Why?
Signal Transduction
8
2021
1608
0.370
Why?
Uterine Neoplasms
5
2009
60
0.360
Why?
Mutation
12
2018
1292
0.360
Why?
Ascites
2
2008
28
0.360
Why?
Carboplatin
2
2009
51
0.360
Why?
Antineoplastic Agents
9
2014
1175
0.350
Why?
Antibodies, Monoclonal
5
2021
457
0.350
Why?
NAD(P)H Dehydrogenase (Quinone)
1
2010
13
0.350
Why?
Cohort Studies
13
2024
1403
0.350
Why?
Proto-Oncogene Proteins c-mdm2
1
2010
12
0.350
Why?
Disease Progression
6
2020
820
0.340
Why?
GTPase-Activating Proteins
1
2009
23
0.340
Why?
Membrane Glycoproteins
2
2009
244
0.340
Why?
Base Sequence
8
2019
657
0.340
Why?
DNA, Neoplasm
11
2006
145
0.340
Why?
Chromosomes, Human, Pair 11
3
2005
54
0.330
Why?
Matrix Metalloproteinase 9
1
2009
86
0.330
Why?
Neoplasms, Glandular and Epithelial
3
2006
41
0.330
Why?
Brachytherapy
9
2014
46
0.330
Why?
Proto-Oncogene Proteins c-myc
2
2021
50
0.320
Why?
Combined Modality Therapy
11
2010
638
0.320
Why?
Abdominal Neoplasms
1
2009
16
0.320
Why?
DNA Repair
11
2007
185
0.320
Why?
Retrospective Studies
33
2024
6123
0.320
Why?
Laser Coagulation
1
2009
26
0.320
Why?
Drug Administration Schedule
10
2013
369
0.310
Why?
Deoxycytidine
4
2006
28
0.310
Why?
Homeodomain Proteins
2
2006
83
0.310
Why?
RNA-Binding Proteins
2
2021
120
0.310
Why?
Microsatellite Instability
5
2019
18
0.300
Why?
Germ-Line Mutation
3
2024
61
0.300
Why?
Protozoan Proteins
1
2008
32
0.300
Why?
Laparoscopy
3
2022
170
0.300
Why?
Kaplan-Meier Estimate
6
2019
463
0.300
Why?
Drug Resistance, Neoplasm
6
2016
314
0.290
Why?
Ovariectomy
7
2010
113
0.290
Why?
Antigens, CD
2
2007
215
0.290
Why?
Chromosomes, Human, Pair 3
4
2001
19
0.280
Why?
Heart Arrest
1
2009
150
0.280
Why?
SOXC Transcription Factors
2
2019
13
0.280
Why?
Polymerase Chain Reaction
9
2010
456
0.280
Why?
Receptors, Estrogen
3
2024
130
0.280
Why?
Topotecan
5
2013
17
0.270
Why?
POU Domain Factors
1
2006
1
0.270
Why?
Registries
6
2010
522
0.260
Why?
Vulvar Neoplasms
5
2002
58
0.260
Why?
Oligonucleotide Array Sequence Analysis
5
2010
409
0.260
Why?
Neoplasm Metastasis
5
2021
235
0.260
Why?
HeLa Cells
3
2021
257
0.260
Why?
Anemia
3
2020
66
0.260
Why?
Survival Rate
10
2009
905
0.250
Why?
Young Adult
7
2018
4029
0.250
Why?
Vaginal Smears
6
2006
28
0.250
Why?
Breast Neoplasms
5
2018
1183
0.250
Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2007
579
0.240
Why?
Chromosome Aberrations
1
2006
295
0.230
Why?
Virus Integration
2
2021
8
0.230
Why?
HSP70 Heat-Shock Proteins
1
2004
62
0.230
Why?
Receptors, Androgen
1
2024
46
0.230
Why?
Receptors, Progesterone
1
2024
63
0.230
Why?
Cystadenocarcinoma, Papillary
2
2002
14
0.220
Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
16
0.220
Why?
Quinazolines
1
2003
32
0.220
Why?
Oncostatin M
2
2021
5
0.220
Why?
Antigens, Neoplasm
1
2004
146
0.220
Why?
Genome-Wide Association Study
2
2017
163
0.220
Why?
Polymorphism, Genetic
5
2018
181
0.220
Why?
Small Cell Lung Carcinoma
1
2023
27
0.210
Why?
Case-Control Studies
7
2019
1128
0.210
Why?
Omentum
1
2002
15
0.210
Why?
Treatment Outcome
23
2014
5176
0.210
Why?
Chromosome Deletion
3
2000
138
0.210
Why?
Proto-Oncogene Proteins c-akt
2
2014
155
0.200
Why?
Linkage Disequilibrium
3
2017
36
0.200
Why?
Neoadjuvant Therapy
2
2022
118
0.200
Why?
Antibodies, Monoclonal, Humanized
5
2013
223
0.200
Why?
Genetic Variation
4
2019
215
0.200
Why?
Tumor Microenvironment
2
2021
221
0.200
Why?
Eukaryotic Initiation Factor-4F
1
2021
1
0.200
Why?
Base Pair Mismatch
5
2006
22
0.200
Why?
CA-125 Antigen
3
2008
16
0.200
Why?
Postoperative Complications
3
2022
1018
0.200
Why?
Suction
1
2001
23
0.200
Why?
Chemoradiotherapy
1
2022
42
0.190
Why?
Oncostatin M Receptor beta Subunit
1
2021
1
0.190
Why?
Smoking
1
2005
506
0.190
Why?
Radiotherapy, Conformal
2
2014
53
0.190
Why?
Proteins
5
2008
347
0.190
Why?
Carcinoma in Situ
2
2013
73
0.190
Why?
Colorectal Neoplasms
3
2002
253
0.190
Why?
Adaptor Proteins, Signal Transducing
8
2007
197
0.190
Why?
Antimetabolites, Antineoplastic
2
2002
37
0.180
Why?
Gene Regulatory Networks
2
2019
107
0.180
Why?
Fetofetal Transfusion
1
2020
6
0.180
Why?
Polycythemia
1
2020
9
0.180
Why?
Pregnancy, Twin
1
2020
7
0.180
Why?
Minority Groups
1
2022
130
0.180
Why?
Radiotherapy
3
2010
124
0.180
Why?
Twins, Monozygotic
1
2020
16
0.180
Why?
Sarcoma
3
2009
65
0.180
Why?
Genetic Diseases, Inborn
1
2000
21
0.180
Why?
Lymph Node Excision
7
2019
138
0.180
Why?
Transcriptome
2
2020
312
0.180
Why?
Patient Satisfaction
2
2006
278
0.180
Why?
Phosphoproteins
2
2016
111
0.180
Why?
Receptor, erbB-3
1
2020
1
0.180
Why?
Furin
1
2020
3
0.180
Why?
HLA-DQ Antigens
1
2000
3
0.170
Why?
Receptor, IGF Type 1
1
2020
20
0.170
Why?
Tomography, X-Ray Computed
7
2013
1150
0.170
Why?
Mice, Nude
4
2021
252
0.170
Why?
Tumor Cells, Cultured
7
2021
462
0.170
Why?
RNA, Neoplasm
3
2007
45
0.170
Why?
Prenatal Diagnosis
1
2020
104
0.170
Why?
Antibodies, Neoplasm
1
2019
28
0.170
Why?
Students
1
2022
220
0.170
Why?
Papillomavirus E7 Proteins
2
2017
31
0.170
Why?
Adolescent
13
2018
6414
0.160
Why?
NM23 Nucleoside Diphosphate Kinases
1
2019
4
0.160
Why?
Reproducibility of Results
2
2022
1182
0.160
Why?
Placenta
1
2020
129
0.160
Why?
Follow-Up Studies
13
2019
2175
0.160
Why?
Indocyanine Green
1
2019
34
0.160
Why?
Doxorubicin
4
2009
233
0.160
Why?
Decision Making
1
2001
273
0.150
Why?
Fallopian Tube Neoplasms
3
2008
14
0.150
Why?
Salvage Therapy
3
2008
136
0.150
Why?
Cyclooxygenase 2
2
2017
43
0.150
Why?
Sequence Analysis, DNA
1
2019
237
0.150
Why?
Lung Neoplasms
2
2023
600
0.150
Why?
Transcription Factors
1
2021
565
0.150
Why?
HLA-DRB1 Chains
1
2017
5
0.150
Why?
HLA-B Antigens
1
2017
7
0.150
Why?
Metabolic Networks and Pathways
1
2018
90
0.150
Why?
DNA Copy Number Variations
1
2018
108
0.150
Why?
Tumor Suppressor Proteins
3
2005
127
0.140
Why?
Receptors, Vitronectin
1
1997
1
0.140
Why?
Carcinoma, Adenosquamous
3
2009
8
0.140
Why?
Proto-Oncogene Proteins
5
2004
155
0.140
Why?
DNA Mutational Analysis
9
2005
176
0.140
Why?
Bayes Theorem
1
2017
105
0.140
Why?
Adipose Tissue
1
2019
188
0.140
Why?
Interleukin-10
1
2017
83
0.140
Why?
Cyclooxygenase 2 Inhibitors
1
2017
17
0.140
Why?
In Situ Hybridization
3
2008
63
0.140
Why?
Leukocytes, Mononuclear
1
2017
112
0.140
Why?
Protein Binding
1
2019
656
0.140
Why?
Animals
10
2021
13100
0.140
Why?
Radiotherapy, Intensity-Modulated
2
2009
174
0.140
Why?
Gene Expression Regulation, Viral
1
2017
48
0.140
Why?
Risk Assessment
9
2019
1254
0.140
Why?
Body Mass Index
3
2010
648
0.140
Why?
Radiotherapy Dosage
8
2014
246
0.140
Why?
Radiation Injuries
3
2008
110
0.130
Why?
ROC Curve
1
2017
225
0.130
Why?
Carrier Proteins
7
2006
302
0.130
Why?
Taxoids
3
2006
37
0.130
Why?
Diagnosis, Differential
4
2024
1036
0.130
Why?
Biopsy
5
2006
591
0.130
Why?
Prospective Studies
10
2019
2345
0.130
Why?
Estrogens
1
2017
222
0.130
Why?
Colposcopy
3
2006
18
0.130
Why?
Molecular Sequence Data
5
2009
799
0.130
Why?
Wound Healing
2
2018
201
0.130
Why?
Cells, Cultured
2
2017
1587
0.120
Why?
Double-Blind Method
1
2017
679
0.120
Why?
Mice
6
2021
5658
0.120
Why?
Carcinosarcoma
3
2019
18
0.120
Why?
Algorithms
1
2019
613
0.120
Why?
Protein Kinase Inhibitors
2
2014
205
0.120
Why?
Apoptosis
2
2021
1092
0.120
Why?
Ultrasonography, Doppler, Color
1
1995
31
0.120
Why?
Sensitivity and Specificity
4
2006
858
0.120
Why?
Dose-Response Relationship, Drug
6
2008
1354
0.120
Why?
Aneurysm
1
1995
33
0.120
Why?
Phosphatidylinositol 3-Kinases
2
2014
139
0.120
Why?
DNA Primers
2
2006
208
0.120
Why?
Obesity
5
2010
1096
0.120
Why?
Platinum Compounds
4
2008
11
0.120
Why?
Heterocyclic Compounds, 3-Ring
1
2014
4
0.120
Why?
Cyclohexanones
1
2014
5
0.120
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2004
11
0.110
Why?
Embolization, Therapeutic
1
1995
85
0.110
Why?
Transcriptional Activation
2
2019
121
0.110
Why?
Camptothecin
3
2010
16
0.110
Why?
TOR Serine-Threonine Kinases
1
2014
76
0.110
Why?
Genetic Association Studies
1
2014
115
0.110
Why?
Paclitaxel
4
2007
83
0.110
Why?
Introns
1
2013
50
0.110
Why?
Hypercalcemia
1
1993
33
0.110
Why?
Decision Support Techniques
2
2010
71
0.110
Why?
Chromosome Mapping
3
2005
158
0.110
Why?
Pyridines
1
2014
133
0.110
Why?
Cell Transformation, Neoplastic
2
2006
181
0.110
Why?
Brain Neoplasms
1
2016
282
0.100
Why?
Dermatologic Surgical Procedures
1
1992
35
0.100
Why?
Models, Genetic
1
2012
174
0.100
Why?
Tomography, Emission-Computed
4
2005
53
0.100
Why?
Keratinocytes
2
2006
90
0.100
Why?
Groin
2
2002
16
0.100
Why?
RNA, Messenger
4
2021
1099
0.100
Why?
Glucose
1
2014
337
0.100
Why?
Cystadenocarcinoma, Serous
2
2024
71
0.100
Why?
Laser Therapy
1
1992
84
0.100
Why?
Exons
3
2007
96
0.100
Why?
Pyrazoles
2
2023
111
0.100
Why?
Infusions, Intravenous
4
2006
212
0.100
Why?
Heterozygote
2
2004
81
0.100
Why?
Condylomata Acuminata
1
1991
4
0.090
Why?
Magnetic Resonance Imaging
3
2014
1525
0.090
Why?
Models, Statistical
1
2012
225
0.090
Why?
Epithelium
2
2007
65
0.090
Why?
Goserelin
1
2010
1
0.090
Why?
Decision Trees
1
2010
19
0.090
Why?
Estrogen Antagonists
1
2010
21
0.090
Why?
Ileal Diseases
1
1990
4
0.090
Why?
Predictive Value of Tests
6
2010
907
0.090
Why?
Leiomyoma
1
1990
25
0.090
Why?
Epigenesis, Genetic
2
2019
370
0.090
Why?
Cell Differentiation
2
2009
649
0.090
Why?
Polymorphism, Restriction Fragment Length
1
2010
66
0.090
Why?
Restriction Mapping
3
2006
33
0.090
Why?
Gastrointestinal Hemorrhage
1
1990
79
0.090
Why?
Colonic Neoplasms
2
2004
158
0.090
Why?
Skin Transplantation
1
1990
43
0.080
Why?
Down-Regulation
4
2020
342
0.080
Why?
Age Factors
4
2006
1092
0.080
Why?
Fluorouracil
2
2006
55
0.080
Why?
Maximum Tolerated Dose
5
2010
38
0.080
Why?
Endometrium
3
2019
40
0.080
Why?
Genome, Human
2
2008
110
0.080
Why?
Urinary Bladder Diseases
1
2009
18
0.080
Why?
Intestinal Diseases
1
2009
26
0.080
Why?
Lasers, Gas
1
2009
7
0.080
Why?
Embolism, Air
1
2009
12
0.080
Why?
Transcription, Genetic
4
2019
370
0.080
Why?
Lymphatic Vessels
1
2009
53
0.080
Why?
Vaginal Neoplasms
2
2005
4
0.080
Why?
Adenocarcinoma, Clear Cell
3
2019
34
0.080
Why?
Fluorine Radioisotopes
1
2008
24
0.080
Why?
Primary Ovarian Insufficiency
1
2008
4
0.080
Why?
Infertility, Female
1
2008
18
0.080
Why?
Eimeria
1
2008
3
0.080
Why?
Haplotypes
2
2017
82
0.080
Why?
Polyethylene Glycols
2
2006
85
0.080
Why?
Up-Regulation
2
2020
446
0.080
Why?
Ubiquitin
1
2008
45
0.080
Why?
Cell Cycle Proteins
1
2009
167
0.080
Why?
Angiogenesis Inhibitors
2
2006
182
0.080
Why?
Tumor Burden
2
2021
131
0.080
Why?
Cricetinae
1
2008
211
0.080
Why?
Expressed Sequence Tags
1
2007
8
0.080
Why?
Infusion Pumps
1
1987
13
0.070
Why?
Fluorescent Antibody Technique
1
2007
112
0.070
Why?
Diagnostic Imaging
1
2009
179
0.070
Why?
Microdissection
1
2007
19
0.070
Why?
Models, Biological
2
2008
719
0.070
Why?
Precancerous Conditions
2
2005
83
0.070
Why?
MutS Homolog 2 Protein
5
2007
12
0.070
Why?
Aorta
3
2005
162
0.070
Why?
Stromal Cells
1
2007
72
0.070
Why?
Organ Specificity
2
2018
106
0.070
Why?
Lasers
1
2007
107
0.070
Why?
Codon
2
2003
47
0.070
Why?
Pelvic Floor
1
2007
51
0.070
Why?
Recombinant Proteins
1
2008
482
0.070
Why?
RNA, Double-Stranded
1
2006
21
0.070
Why?
Neutropenia
1
2007
114
0.070
Why?
Polymorphism, Single-Stranded Conformational
6
2003
19
0.070
Why?
Tissue Fixation
1
2006
36
0.070
Why?
Intestinal Perforation
2
2006
23
0.070
Why?
Specimen Handling
1
2006
54
0.070
Why?
Pulmonary Embolism
1
1987
97
0.070
Why?
Head and Neck Neoplasms
2
2016
281
0.070
Why?
Protein Kinases
1
2006
70
0.070
Why?
Chromosomes, Artificial, Yeast
3
2000
7
0.060
Why?
Endometrial Hyperplasia
2
2002
14
0.060
Why?
Proportional Hazards Models
4
2010
404
0.060
Why?
Abdomen
1
2006
75
0.060
Why?
Papillomavirus Vaccines
1
2006
67
0.060
Why?
Recurrence
4
2010
658
0.060
Why?
Neovascularization, Pathologic
1
2006
153
0.060
Why?
Probability
4
2007
163
0.060
Why?
Terminal Care
1
2005
46
0.060
Why?
Dibenzocycloheptenes
1
2004
1
0.060
Why?
Male
11
2018
25437
0.060
Why?
Radiation-Sensitizing Agents
1
2005
51
0.060
Why?
Cell Adhesion Molecules
1
2005
87
0.060
Why?
Quinolines
1
2004
41
0.060
Why?
Tumor Suppressor Protein p53
1
2006
213
0.060
Why?
Amyloid
1
2004
26
0.060
Why?
Tissue Distribution
1
2004
163
0.060
Why?
Genes, Viral
1
2003
38
0.060
Why?
Lactones
1
2003
25
0.060
Why?
Enzyme-Linked Immunosorbent Assay
1
2004
234
0.060
Why?
Abdomen, Acute
1
2003
6
0.060
Why?
Thrombospondins
1
2003
8
0.050
Why?
Biopsy, Needle
4
2006
182
0.050
Why?
Obesity, Morbid
1
2004
74
0.050
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2003
57
0.050
Why?
Pyrimidinones
1
2023
18
0.050
Why?
RNA, Viral
2
2016
124
0.050
Why?
Fibroma
1
2003
39
0.050
Why?
Clinical Competence
1
2006
395
0.050
Why?
Neoplasms, Second Primary
1
2004
74
0.050
Why?
Radiotherapy, Adjuvant
3
2010
60
0.050
Why?
Congenital Abnormalities
1
2004
112
0.050
Why?
Uterine Hemorrhage
1
2002
8
0.050
Why?
Age of Onset
2
2004
108
0.050
Why?
PTEN Phosphohydrolase
2
2019
53
0.050
Why?
Pneumatosis Cystoides Intestinalis
1
2002
7
0.050
Why?
DNA, Ribosomal
1
2002
28
0.050
Why?
Blood Transfusion, Autologous
1
2002
4
0.050
Why?
Chromatography, High Pressure Liquid
1
2003
326
0.050
Why?
Genital Diseases, Female
1
2002
17
0.050
Why?
Pregnancy
3
2020
2468
0.050
Why?
Acridines
1
2002
4
0.050
Why?
Postmenopause
1
2002
76
0.050
Why?
Medical History Taking
1
2002
47
0.050
Why?
Medical Records
1
2002
85
0.050
Why?
Blood Donors
1
2002
31
0.050
Why?
Complementary Therapies
1
2002
25
0.050
Why?
Family Health
1
2002
79
0.050
Why?
AU Rich Elements
1
2021
1
0.050
Why?
Peptide Chain Initiation, Translational
1
2021
15
0.050
Why?
RNA Stability
1
2021
24
0.050
Why?
Cytokine Receptor gp130
1
2021
12
0.050
Why?
3' Untranslated Regions
1
2021
53
0.050
Why?
Receptors, Transforming Growth Factor beta
1
2001
25
0.050
Why?
Lymphatic Irradiation
1
2001
1
0.050
Why?
Blotting, Northern
2
2001
110
0.050
Why?
Prostaglandin-Endoperoxide Synthases
1
2001
24
0.050
Why?
Blotting, Southern
3
2002
43
0.050
Why?
Xenograft Model Antitumor Assays
1
2021
212
0.050
Why?
Internship and Residency
1
2006
442
0.050
Why?
Phosphoric Monoester Hydrolases
1
2000
21
0.050
Why?
Equipment Design
1
2001
286
0.050
Why?
Catheterization, Central Venous
1
2001
84
0.050
Why?
Blood Vessels
1
2001
71
0.050
Why?
Uganda
1
2020
36
0.050
Why?
Incidence
3
2007
986
0.040
Why?
Quality Improvement
1
2022
205
0.040
Why?
Isoenzymes
1
2001
168
0.040
Why?
Logistic Models
2
2017
895
0.040
Why?
Risk Management
1
2000
32
0.040
Why?
Physical Chromosome Mapping
1
2000
7
0.040
Why?
beta Karyopherins
1
2019
4
0.040
Why?
Patient Discharge
1
2022
318
0.040
Why?
Interviews as Topic
1
2001
261
0.040
Why?
Acid Anhydride Hydrolases
1
1999
13
0.040
Why?
Cell Survival
1
2021
590
0.040
Why?
DNA Repair Enzymes
1
1999
42
0.040
Why?
Adenosine Triphosphatases
1
1999
87
0.040
Why?
Cell Nucleus
1
2019
186
0.040
Why?
Pregnancy Outcome
1
2020
205
0.040
Why?
Cross-Sectional Studies
1
2024
1573
0.040
Why?
Molecular Targeted Therapy
1
2019
121
0.040
Why?
Regression Analysis
3
2006
385
0.040
Why?
Chromosomes, Human, Pair 10
1
1998
3
0.040
Why?
Coloring Agents
1
2019
67
0.040
Why?
Gene Dosage
1
2018
78
0.040
Why?
Histone Demethylases
1
2018
16
0.040
Why?
Th1-Th2 Balance
1
2018
2
0.040
Why?
Leptin
1
2019
137
0.040
Why?
Epithelial-Mesenchymal Transition
1
2018
49
0.040
Why?
Estradiol
1
2019
213
0.040
Why?
Major Histocompatibility Complex
1
2017
12
0.040
Why?
Databases, Genetic
1
2018
87
0.040
Why?
Genotyping Techniques
1
2017
20
0.040
Why?
Child
4
2018
6844
0.040
Why?
Chemokines
1
2017
75
0.040
Why?
Receptors, Collagen
1
1997
3
0.040
Why?
Receptors, Fibronectin
1
1997
5
0.040
Why?
Time Factors
4
2010
2891
0.040
Why?
Mass Screening
1
2000
346
0.040
Why?
Coculture Techniques
1
2017
143
0.040
Why?
Transforming Growth Factor beta
1
2018
136
0.040
Why?
Interferon-gamma
1
2018
176
0.040
Why?
Integrins
1
1997
30
0.040
Why?
Chemotherapy, Adjuvant
2
2010
121
0.040
Why?
Quality-Adjusted Life Years
2
2010
63
0.030
Why?
Diet, High-Fat
1
2019
214
0.030
Why?
Longitudinal Studies
1
2019
693
0.030
Why?
Epithelial Cells
2
2006
209
0.030
Why?
Hepatitis Viruses
1
2016
2
0.030
Why?
Herpesviridae
1
2016
17
0.030
Why?
Viruses
1
2016
21
0.030
Why?
Host-Pathogen Interactions
1
2017
136
0.030
Why?
Gastrointestinal Neoplasms
1
2016
40
0.030
Why?
Mice, Transgenic
1
2017
543
0.030
Why?
DNA Replication
1
1997
151
0.030
Why?
Cost-Benefit Analysis
2
2010
269
0.030
Why?
Plasmids
2
2001
164
0.030
Why?
Sequence Analysis, RNA
1
2016
88
0.030
Why?
Central Nervous System Neoplasms
1
2016
64
0.030
Why?
Electrosurgery
1
1995
7
0.030
Why?
Fibroblasts
1
2017
352
0.030
Why?
Macrophages
1
2018
361
0.030
Why?
Prostatic Neoplasms
1
1998
391
0.030
Why?
CpG Islands
2
2008
106
0.030
Why?
DNA Probes, HPV
2
1991
3
0.030
Why?
Computational Biology
1
2016
214
0.030
Why?
Arteries
1
1995
91
0.030
Why?
Cytokines
1
2017
607
0.030
Why?
Class I Phosphatidylinositol 3-Kinases
1
2014
17
0.030
Why?
Multivariate Analysis
2
2009
579
0.030
Why?
Treatment Failure
2
2008
116
0.030
Why?
Missouri
2
2006
64
0.030
Why?
Organs at Risk
1
2014
70
0.030
Why?
Inclusion Bodies
1
1993
18
0.030
Why?
Cell Division
2
1994
294
0.030
Why?
Parathyroid Hormone-Related Protein
1
1993
22
0.030
Why?
Cell Death
1
2014
174
0.030
Why?
Imaging, Three-Dimensional
1
2014
152
0.030
Why?
Risk
2
2004
314
0.030
Why?
Skin Physiological Phenomena
1
1992
15
0.030
Why?
Guinea Pigs
1
1992
75
0.030
Why?
Epidermis
1
1992
28
0.030
Why?
Pelvis
2
2004
66
0.030
Why?
Pedigree
2
2004
125
0.020
Why?
Deoxyglucose
1
2012
36
0.020
Why?
Regeneration
1
1992
72
0.020
Why?
Colectomy
1
1992
34
0.020
Why?
Computer Simulation
1
2012
281
0.020
Why?
Pilot Projects
2
2004
702
0.020
Why?
Sequence Deletion
2
2003
69
0.020
Why?
Premenopause
1
2010
24
0.020
Why?
Amino Acid Sequence
2
2003
579
0.020
Why?
Staurosporine
1
2010
12
0.020
Why?
Anastomosis, Surgical
1
1990
66
0.020
Why?
Remission Induction
1
2010
205
0.020
Why?
Molecular Weight
1
1990
85
0.020
Why?
Proto-Oncogene Proteins p21(ras)
2
2001
66
0.020
Why?
ras Proteins
2
2001
65
0.020
Why?
Cicatrix
1
1990
40
0.020
Why?
Hemoglobins
1
1990
106
0.020
Why?
Staining and Labeling
1
1990
97
0.020
Why?
Chi-Square Distribution
1
2010
275
0.020
Why?
Perioperative Care
1
2009
42
0.020
Why?
Urinary Incontinence
1
2009
38
0.020
Why?
Organoplatinum Compounds
1
2008
15
0.020
Why?
Gene Knockdown Techniques
1
2009
106
0.020
Why?
Vinblastine
1
2008
23
0.020
Why?
Fetus
1
1990
214
0.020
Why?
Life Style
1
2009
140
0.020
Why?
Dose-Response Relationship, Radiation
1
2008
183
0.020
Why?
Emotions
1
2009
164
0.020
Why?
Cell Line
1
1990
1010
0.020
Why?
Cadherins
1
2007
64
0.020
Why?
Demography
1
2007
93
0.020
Why?
Intracellular Signaling Peptides and Proteins
1
2008
139
0.020
Why?
Cytoplasmic Structures
1
2006
1
0.020
Why?
Skin
1
1990
415
0.020
Why?
DNA Mismatch Repair
1
2006
16
0.020
Why?
Waxes
1
2006
1
0.020
Why?
Tissue Embedding
1
2006
1
0.020
Why?
Eukaryotic Initiation Factor-2
1
2006
16
0.020
Why?
NIH 3T3 Cells
1
2006
51
0.020
Why?
Immunoenzyme Techniques
2
2001
141
0.020
Why?
Tomography Scanners, X-Ray Computed
1
2006
12
0.020
Why?
Chromosomal Instability
1
2006
16
0.020
Why?
Neoplasm, Residual
1
2007
156
0.020
Why?
Cryopreservation
1
2006
31
0.020
Why?
Genome, Viral
1
2006
78
0.020
Why?
Analysis of Variance
1
2007
552
0.020
Why?
Transfection
1
2006
354
0.020
Why?
Mutation, Missense
1
2006
103
0.020
Why?
Nurse Practitioners
1
2006
42
0.020
Why?
Gene Expression
1
2008
612
0.020
Why?
Gynecology
1
2006
49
0.020
Why?
Early Diagnosis
1
2006
87
0.020
Why?
Ovarian Cysts
1
2005
4
0.020
Why?
Medical Futility
1
2005
8
0.020
Why?
Sarcoma, Endometrial Stromal
1
2005
1
0.020
Why?
Cyclophosphamide
1
2006
163
0.020
Why?
Triage
1
2006
61
0.020
Why?
Leiomyosarcoma
1
2005
23
0.020
Why?
Hospice Care
1
2005
26
0.020
Why?
Cytodiagnosis
1
2005
42
0.020
Why?
Health Services
1
2005
65
0.020
Why?
Phosphorylation
1
2006
526
0.020
Why?
Obstetrics
1
2006
86
0.020
Why?
Lymphatic System
1
2004
13
0.010
Why?
Penetrance
1
2004
6
0.010
Why?
Area Under Curve
1
2004
178
0.010
Why?
Microscopy, Electron, Transmission
1
2004
75
0.010
Why?
Calcification, Physiologic
1
2004
40
0.010
Why?
Laparotomy
1
2004
35
0.010
Why?
Bryostatins
1
2003
1
0.010
Why?
Macrolides
1
2003
16
0.010
Why?
Ethanol
1
2006
335
0.010
Why?
Genomic Instability
1
2004
91
0.010
Why?
Tamoxifen
1
2004
59
0.010
Why?
Thrombospondin 1
1
2003
7
0.010
Why?
Genes, p16
1
2003
9
0.010
Why?
Confidence Intervals
1
2003
154
0.010
Why?
Codon, Terminator
1
2003
8
0.010
Why?
Administration, Oral
1
2004
433
0.010
Why?
Frameshift Mutation
1
2003
17
0.010
Why?
Palliative Care
1
2005
185
0.010
Why?
Mutagenesis, Insertional
1
2003
24
0.010
Why?
Liposomes
1
2003
52
0.010
Why?
Body Weight
1
2005
512
0.010
Why?
Cytoskeletal Proteins
1
2003
49
0.010
Why?
DNA Transposable Elements
1
2003
105
0.010
Why?
Physicians
1
2006
229
0.010
Why?
Prevalence
1
2006
956
0.010
Why?
Reference Values
1
2003
302
0.010
Why?
beta Catenin
1
2003
101
0.010
Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
Why?
Retinoblastoma Protein
1
2002
18
0.010
Why?
Ifosfamide
1
2002
8
0.010
Why?
Documentation
1
2002
33
0.010
Why?
Trans-Activators
1
2003
134
0.010
Why?
Bleomycin
1
2002
34
0.010
Why?
Hospitals, University
1
2002
77
0.010
Why?
Antineoplastic Agents, Alkylating
1
2002
74
0.010
Why?
Age Distribution
1
2002
169
0.010
Why?
Equipment Failure
1
2001
63
0.010
Why?
Statistics, Nonparametric
1
2002
193
0.010
Why?
Nucleic Acid Hybridization
2
1991
55
0.010
Why?
Antibiotics, Antineoplastic
1
2002
77
0.010
Why?
Carcinoma, Small Cell
1
2001
25
0.010
Why?
Genes, erbB-1
1
2001
8
0.010
Why?
Outpatients
1
2002
112
0.010
Why?
Radiography
1
2002
485
0.010
Why?
Hospitalization
1
2005
663
0.010
Why?
Repetitive Sequences, Nucleic Acid
1
2000
96
0.010
Why?
DNA
1
2004
543
0.010
Why?
Mitogen-Activated Protein Kinases
1
2001
154
0.010
Why?
Genetic Linkage
1
2000
26
0.010
Why?
Chromosomes, Human, Pair 2
1
2000
25
0.010
Why?
Morbidity
1
2000
128
0.010
Why?
Blotting, Western
1
2001
587
0.010
Why?
Gene Deletion
1
2000
267
0.010
Why?
Carcinoma, Non-Small-Cell Lung
1
2001
153
0.010
Why?
Chromosomes, Bacterial
1
1998
14
0.010
Why?
Cloning, Molecular
1
1998
189
0.010
Why?
Infant
1
2006
3572
0.010
Why?
Child, Preschool
1
2006
3875
0.010
Why?
Drug Resistance, Multiple
1
1997
24
0.010
Why?
Antineoplastic Agents, Phytogenic
1
1997
67
0.010
Why?
Gene Frequency
1
1997
95
0.010
Why?
United States
1
2007
4878
0.010
Why?
Dimethyl Sulfoxide
1
1994
12
0.010
Why?
Glycerol
1
1994
15
0.010
Why?
Ambulatory Surgical Procedures
1
1995
51
0.010
Why?
Drug Screening Assays, Antitumor
1
1994
131
0.010
Why?
Drug Carriers
1
1994
69
0.010
Why?
Cell Cycle
1
1994
226
0.010
Why?
Retroperitoneal Space
1
1991
32
0.010
Why?
Rader's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description